Dr. Hanecak is the Assistant Vice Chancellor, Research and Technology Alliances. Dr. Hanecak is responsible for leading the Office of Technology Alliances (OTA). The OTA serves as the focal point for the evaluation, management, and licensing of UCI’s broad intellectual property portfolio (including inventions in the life sciences, biomedical and physical sciences sectors), material transfers, and industry/university interactions involving both research and technology transfer.
Prior to joining UCI in 2002, Dr. Hanecak held research director, project management, and business development positions at Isis Pharmaceuticals, Inc. and Trega Biosciences, Inc. where she managed and expanded multimillion dollar, international research and development collaborations. Drug discovery and development project areas included antisense and small molecule pharmaceutical drug candidates for infectious disease targets, metabolic diseases, inflammatory and immune disorders.
She received her B.A. in Biology from the University of California, San Diego and a Ph.D. in Microbiology from the State University of New York at Stony Brook (now known as Stony Brook University).
As the Associate Director, Intellectual Property Administration, Kevin is responsible for overseeing the negotiation of Material Transfer Agreements and compliance with legal, policy and procedural aspects of license agreements (patent and copyright). Kevin also reviews and negotiates the intellectual property terms in a wide range of campus agreements including multiparty collaborative research agreements, UCI sponsored research agreements involving technology licenses, equipment loan agreements and international agreements. Prior to joining UCI in 2000, Kevin worked in Regulatory Affairs at several medical device companies, Karl Storz Endoscopy, the U.S. unit of German medical device company which developed and manufactured endoscopic devices, and Medical Analysis Systems, Inc., a developer and manufacturer of vitro diagnostics. At Karl Storz Kevin was responsible for FDA premarket submission activities for the US and Canadian markets, including managing multi-center clinical studies and conducting clinical monitoring. At Medical Analysis Systems, Inc., Kevin was responsible for scheduling and conducting QSR and ISO 9001 compliance audits of both internal departments and outside contract vendors as well as FDA premarket submission activities for the US market.
Kevin received his B. S., Biochemistry as well as a Juris Doctor in Law from the University of Wisconsin, Madison.
Doug is a Senior Licensing Officer for Physical Sciences with the Office of Technology Alliances (OTA). Doug primarily focuses on engineering, energy, software/copyright, and physical science technologies as well as select medical devices. Prior to coming to UC Irvine in 2006, Doug held licensing positions of increasing responsibility and complexity at both the University of California’s Office of the President as well as at UC Berkeley. Before he began his career in licensing, Doug spent two years as Director of Marketing for an energy services firm, ReEnergize. Earlier in his career, Doug spent 11 years working in low-energy plasma physics and technology transfer at the Lawrence Berkeley National Laboratory, where he helped develop new light sources for the Department of Energy. Doug received his B.A. in Physics from the University of California, Berkeley and an MBA from St. Mary’s College.
Alvin is the Interim Associate Director for the Engineering and Physical Sciences group with the Office of Technology Alliances (OTA). Alvin reviews new invention disclosures for patentability and commercial viability, and connects with industry for licensing opportunities. He currently manages more than 200 inventions including technologies from UCI’s Biomedical Engineering department, School of Medicine, and UCI’s Medical Center. Alvin drafts and negotiates agreements for UCI’s latest company spinoffs and startups. He is actively involved in academic and community outreach and frequently speaks on topics such as Patents, Licensing and Commercialization of new technologies. Before joining UCI’s OTA, Alvin was IP Counsel for Cengent Therapeutics (formerly Structural BioInformatics). Alvin received his B.S. in Biology from UC Irvine before graduating from the University of San Diego School of Law and passing the California Bar and USPTO Patent Bar.
Holger Roehl is an Assistant Director, Alliance Development. Holger manages a portfolio of life science and medical inventions and assists with the formation of UCI startups companies. Prior to returning to academia, Holger held research and management positions at biotechnology companies such as BioMedica, Inc., Chiron Corporation, Cell Genesys, Inc., and he has been a consultant for various start-up and early-stage ventures. During his 10 years working in the biotechnology industry, Holger has been mainly involved in the development of therapeutics with an emphasis on biologics and gene therapy applications.
Holger performed undergraduate studies in biology at the University of Konstanz/Germany. He received his Ph.D. in Microbiology and Public Health from Michigan State University, and his MBA from UC Irvine.
As a Senior Licensing Officer, Casie works closely with faculty, staff, and students to help identify aspects of their research with commercial potential. Her responsibilities include evaluating new inventions, managing all aspects of patent prosecution within her portfolio of inventions, and licensing the university’s patent rights to both established companies and startups. Casie also oversees OTA’s internship program. Prior to joining UCI in 2012, Casie worked for six years at UCLA’s technology transfer office, where she managed a large portfolio of life science inventions. Casie is a named inventor on 7 issued US patents and previously developed therapeutic monoclonal antibodies that are in clinical development by a major pharmaceutical company. Casie earned her Ph.D. in Microbiology & Molecular Genetics from Harvard University and B.S. degrees in Chemistry and in Microbiology from UCLA. Casie is a registered patent agent at the USPTO.
Maria Tkachuk joined the Office of Technology Alliances (OTA) at UC Irvine in January 2006. Her portfolio of technologies includes small molecules, polymers, chemicals, metabolic modulators, research tools, and antibodies.
Maria received her BS in Biochemistry from Moscow State University, Moscow, Russia and earned a Ph.D. in Cell Biology at the Basel University in Basel, Switzerland. Her postdoctoral work was done at Stanford University, in the laboratory of Professor Irving Weissman (stem cell research). Maria has passed the Patent Bar and is registered as a Patent Agent at the US Patent and Trademark Office. She is a member of the Licensing Executives Society and the Association of University Technology Managers.
Michael Harpen is a Licensing Officer with the Office of Technology Alliances (OTA). Prior to joining OTA in 2015, he did technology collaborations work at Washington State University, the International Atomic Energy Agency, and the Pennington Biomedical Research Foundation, among others. He has B.S. in Chemical Engineering from the University of South Alabama and a J.D. in Law from Louisiana State University.
Stephen is a Technology Manager in the Office of Technology Alliances. His responsibilities include assisting the licensing staff in the evaluation of technologies for patentable subject matter and researching the commercial potential of early stage discoveries in the life science and medical sectors, including the identification of potential licensees. He also implements office processes for the evaluation of UCI inventions. As a Technology Manager, Stephen works closely with the licensing officers to increase faculty interest in the technology transfer process. Prior to joining UCI in 2013, Stephen held positions at Teva Parenteral Medicines ("Teva") and Dorsey & Whitney LLP ("Dorsey") where he developed freedom to operate strategies for generic drug products (Teva) and drafted and prosecuted patent applications for various startup and Fortune 500 companies (Dorsey). Stephen holds a Ph.D in Medicinal and Synthetic Chemistry from Simon Fraser University where he conducted research on the synthesis and mechanism of action of anti-bacterial agents.
As a Licensing Analyst / Records Manager, Flor is the central point of contact for the administration of invention disclosures, patent tracking and licensing processes for the Office of Technology Alliances (OTA). Flor has a wide range of responsibilities related to patent licensing activity, and database management. Flor also manages OTA’s electronic records, interfaces with UC Irvine’s patent tracking system, and is responsible for managing OTA’s library of files. She provides support to OTA’s Licensing Officers on issues relating to technology transfer, and coordinates prosecution documentation.
Sue has been with OTA since 1998. As OTA’s Intellectual Property Finance Manager, she is responsible for managing the UC Irvine patent budget. Sue’s responsibilities include the reporting and analysis of technology transfer activity and financial data and reporting data to the UC Office of the President, UC Irvine Budget office and the various schools and departments at UC Irvine.